The FDA already authorizes the use of experimental drugs under what’s called “compassionate use,” for people with no other ...
This move is another step in Makary’s attempts to shorten FDA reviews, which started when he began his tenure last year. 3 These include mandating the use of artificial intelligence for staffers and ...
The FDA is contemplating changing its medical device for software approval process, JD Supra reports. Here’s what you should know. 1. Software as a medical device applies to all software used to ...
The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10 to 12 months for a review to just ...
The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit’s ...
As FDA itself observes, “devices of a new type that FDA has not previously classified … are ‘automatically’ or ‘statutorily’ classified into class III…, regardless of the level of risk they pose.” To ...
Opinion
MedPage Today on MSNOpinion
RFK Jr.'s Anti-Vaccine Stance Infiltrated FDA. Trump Is Reining It In.
Here's what the Moderna flu shot debacle was really about ...
The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results